Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Recent Progression and Perspective

被引:15
|
作者
Takayasu, Kenichi [1 ]
机构
[1] Natl Canc Ctr, Dept Diagnost Radiol, Tokyo 1040045, Japan
关键词
Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Treatment algorithm; Japanese guidelines; BCLC staging system; ENDOTHELIAL GROWTH-FACTOR; TRANSARTERIAL CHEMOEMBOLIZATION; PORTAL-VEIN; IODIZED OIL; EMBOLIZATION; EXPRESSION; THERAPY; TUMOR; CHEMOTHERAPY; RECURRENCE;
D O I
10.1159/000345886
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transcatheter arterial chemoembolization (TACE) is widely performed in 32% of patients with unresectable hepatocellular carcinoma (HCC) at initial diagnosis and in 58% of those with recurrent HCC in Japan. However, the patient population which undergoes TACE is heterogeneous, and thus the 3-year survival rate varies from 26 to 47%. The selection criteria for TACE is 2-3 tumors >3 cm or 4 or more tumors in patients with liver damage A/B (corresponding well to Child-Pugh class A/B) and absence of vascular invasion and extrahepatic spread, as proposed by Japanese guidelines. The 3-year survival rate of TACE for patients with 2-3 tumors >3 cm or 4 or more tumors was 55 and 46%, respectively, in Child-Pugh A and 30 and 22%, respectively, in class B. These outcomes could help in understanding the various results of TACE in different backgrounds in the East and West. Recently, TACE with calibrated drug-eluting beads loaded with doxorubicin showed a similar tumor response and radioembolization with yttrium-90 microspheres demonstrated a similar median survival compared with conventional TACE. Based on these results, the combination of TACE and novel molecular targeted agents can be used to elucidate the synergic effect on survival. Copyright (C) 2013 S. Karger AG, Basel
引用
收藏
页码:28 / 33
页数:6
相关论文
共 50 条
  • [1] RETRACTED: Superselective Transarterial Chemoembolization for Hepatocellular Carcinoma: Recent Progression and Perspective (Retracted article. See vol. 82, pg. 188, 2012)
    Takayasu, Kenichi
    ONCOLOGY, 2011, 81 : 105 - 110
  • [2] Gemcitabine transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma
    Hammond, John S.
    Franko, Jan
    Holloway, Shane E.
    Heckman, Jason T.
    Orons, Phillip D.
    Gamblin, T. Clark
    HEPATO-GASTROENTEROLOGY, 2014, 61 (133) : 1339 - 1343
  • [3] Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
    Takano, Michitoshi
    Kokudo, Takashi
    Miyazaki, Yoshihiro
    Kageyama, Yumiko
    Takahashi, Amane
    Amikura, Katsumi
    Sakamoto, Hirohiko
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (42) : 9445 - 9450
  • [4] Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma
    Ashoori, N.
    Paprottka, P.
    Trumm, C.
    Bamberg, F.
    Kolligs, F. T.
    Rentsch, M.
    Reiser, M. F.
    Jakobs, T. F.
    DIGESTION, 2012, 85 (01) : 18 - 26
  • [5] Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
    Firouznia, Kavous
    Ghanaati, Hossein
    Alavian, Seyed Moayed
    Azadeh, Payam
    Toosi, Mohsen Nasiri
    Mirzaian, Arya Haj
    Najafi, Safa
    Shakiba, Madjid
    Jalali, Amir Hossein
    HEPATITIS MONTHLY, 2014, 14 (12) : e25792
  • [6] Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma
    Miyayama, Shiro
    Mitsui, Takeshi
    Zen, Yoh
    Sudo, Yoshiko
    Yamashiro, Masashi
    Okuda, Miho
    Yoshie, Yuichi
    Sanada, Taku
    Notsumata, Kazuo
    Tanaka, Nobuyoshi
    Matsui, Osamu
    HEPATOLOGY RESEARCH, 2009, 39 (04) : 374 - 381
  • [7] Transcatheter Arterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Feng, Guoying
    Feng, Yi
    Yao, Shu
    Huang, Xun
    Peng, Zuxiang
    Tang, Yongliang
    Tang, Wen
    Li, Zhengyan
    Wang, Hanchen
    Li, Hongming
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35 (04) : 266 - 279
  • [8] Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma
    Kawabe, Naoto
    Hashimoto, Senju
    Nakano, Takuji
    Nakaoka, Kazunori
    Fukui, Aiko
    Yoshioka, Kentaro
    JGH OPEN, 2021, 5 (06): : 705 - 711
  • [9] Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Imai, Yukinori
    Chikayama, Taku
    Nakazawa, Manabu
    Watanabe, Kazuhiro
    Ando, Satsuki
    Mizuno, Yoshie
    Yoshino, Kiyoko
    Sugawara, Kayoko
    Hamaoka, Kazuhiro
    Fujimori, Kenji
    Inao, Mie
    Nakayama, Nobuaki
    Oka, Masashi
    Nagoshi, Sumiko
    Mochida, Satoshi
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (02) : 179 - 186
  • [10] Combination of Local Transcatheter Arterial Chemoembolization and Systemic Anti-Angiogenic Therapy for Unresectable Hepatocellular Carcinoma
    Liapi, Eleni
    Geschwind, Jean-Francois H.
    LIVER CANCER, 2012, 1 (3-4) : 201 - 215